Sign in
  • USA
  • UK
  • Germany
  • France
  • Canada
  • India
  • Italy
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
LogoFinSMEs The Website About Venture Capital News
LogoFinSMEs The Website About Venture Capital News
  • USA
  • UK
  • Germany
  • France
  • Canada
  • India
  • Italy
Home Tags Vida Ventures

Tag: Vida Ventures

Candid Therapeutics
USA

Candid Therapeutics Raises $370M in Funding

FinSMEs -
September 9, 2024
0
Halda Therapeutics
USA

Halda Therapeutics Raises $126M in Series B Extension Financing

FinSMEs -
August 12, 2024
0
Third Arc Bio
USA

Third Arc Bio Launches with $165M Series A Financing

FinSMEs -
July 23, 2024
0
Scorpion Therapeutics
USA

Scorpion Therapeutics Raises $150M in Series C Financing

FinSMEs -
July 16, 2024
0
Alterome Therapeutics
USA

Alterome Therapeutics Raises $132M in Series B Financing

FinSMEs -
April 8, 2024
0
capstan
USA

Capstan Therapeutics Raises $175M in Series B Financing

FinSMEs -
March 21, 2024
0
avalyn-logo-final
USA

Avalyn Pharma Closes $175M Series C Financing

FinSMEs -
September 27, 2023
0
ReCode_Logo
USA

ReCode Therapeutics Raises Additional USD50M in Series B Financing

FinSMEs -
September 19, 2023
0
Quanta Therapeutics
USA

Quanta Therapeutics Raises Over $50M in Series D Financing

FinSMEs -
May 23, 2023
0
Volastra Therapeutics
USA

Volastra Therapeutics Secures $60M in Series A Funding

FinSMEs -
March 7, 2023
0
cancer
USA

Aktis Oncology Raises $84M in Series A Extension Funding

FinSMEs -
August 26, 2022
0
Affini-T-Therapeutics
USA

Affini-T Therapeutics Closes $175M Financing

FinSMEs -
March 23, 2022
0
Kyverna
USA

Kyverna Therapeutics Raises $85M in Series B Financing

FinSMEs -
January 26, 2022
0
Vida Ventures
USA

Vida Ventures Closes Fund III, At $825M

FinSMEs -
July 4, 2021
0
cancer
USA

Volastra Therapeutics Expands Seed Funding to $44M

FinSMEs -
April 6, 2021
0
123Page 1 of 3
  • Contact
  • About
  • Privacy Policy
  • Advertise with Us
  • Disclaimer
  • GDPR
  • Terms & Conditions

Follow Us

Twitter